65 related articles for article (PubMed ID: 1328848)
21. Human and viral nucleoside/nucleotide kinases involved in antiviral drug activation: structural and catalytic properties.
Deville-Bonne D; El Amri C; Meyer P; Chen Y; Agrofoglio LA; Janin J
Antiviral Res; 2010 Apr; 86(1):101-20. PubMed ID: 20417378
[TBL] [Abstract][Full Text] [Related]
22. Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells.
Sarkar M; Han T; Damaraju V; Carpenter P; Cass CE; Agarwal RP
Biochem Pharmacol; 2005 Aug; 70(3):426-32. PubMed ID: 15950950
[TBL] [Abstract][Full Text] [Related]
23. Dideoxycytidine metabolism in wild type and mutant CEM cells deficient in nucleoside transport or deoxycytidine kinase.
Ullman B
Adv Exp Med Biol; 1989; 253B():415-20. PubMed ID: 2558543
[TBL] [Abstract][Full Text] [Related]
24. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
Kurtzberg J; Hershfield MS
Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
[TBL] [Abstract][Full Text] [Related]
25. Comparative metabolism of E-5-(2-bromovinyl)-2'-deoxyuridine and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in herpes simplex virus-infected cells.
Ayisi NK; Wall RA; Wanklin RJ; Machida H; De Clercq E; Sacks SL
Mol Pharmacol; 1987 Apr; 31(4):422-9. PubMed ID: 3472064
[TBL] [Abstract][Full Text] [Related]
26. Modulation of human UMP/CMP kinase affects activation and cellular sensitivity of deoxycytidine analogs.
Liou JY; Lai HR; Hsu CH; Chang WL; Hsieh MJ; Huang YC; Cheng YC
Biochem Pharmacol; 2010 Feb; 79(3):381-8. PubMed ID: 19765547
[TBL] [Abstract][Full Text] [Related]
27. Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy.
Johnsamuel J; Eriksson S; Oliveira M; Tjarks W
Bioorg Med Chem; 2005 Jul; 13(13):4160-7. PubMed ID: 15876539
[TBL] [Abstract][Full Text] [Related]
28. A biochemical genetic study of the role of specific nucleoside kinases in deoxyadenosine phosphorylation by cultured human cells.
Ullman B; Levinson BB; Hershfield MS; Martin DW
J Biol Chem; 1981 Jan; 256(2):848-52. PubMed ID: 6256370
[No Abstract] [Full Text] [Related]
29. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the antiviral nucleoside 2' ,3'-dideoxyguanosine.
Ahluwalia G; Cooney DA; Bondoc LL; Currens MJ; Ford H; Johns DG; Mitsuya H; Fridland A
Biochem Biophys Res Commun; 1990 Sep; 171(3):1297-303. PubMed ID: 1977386
[TBL] [Abstract][Full Text] [Related]
30. Effects of mutational loss of nucleoside kinases on deoxyadenosine 5'-phosphate/deoxyadenosine substrate cycle in cultured CEM and V79 cells.
Bianchi V; Ferraro P; Borella S; Bonvini P; Reichard P
J Biol Chem; 1994 Jun; 269(24):16677-83. PubMed ID: 8206987
[TBL] [Abstract][Full Text] [Related]
31. Adenosine kinase deficiency in tritiated deoxyadenosine-resistant mouse S49 lymphoma cell lines.
Sastry KJ; Huang C; Chan TS
Biochem Genet; 1987 Dec; 25(11-12):765-77. PubMed ID: 2835956
[TBL] [Abstract][Full Text] [Related]
32. Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5'-nucleotidase.
Bennett LL; Allan PW; Arnett G; Shealy YF; Shewach DS; Mason WS; Fourel I; Parker WB
Antimicrob Agents Chemother; 1998 May; 42(5):1045-51. PubMed ID: 9593124
[TBL] [Abstract][Full Text] [Related]
33. Regulation of purine deoxynucleoside phosphorylation by deoxycytidine kinase from human leukemic blast cells.
Sarup JC; Johnson MA; Verhoef V; Fridland A
Biochem Pharmacol; 1989 Aug; 38(16):2601-7. PubMed ID: 2548513
[TBL] [Abstract][Full Text] [Related]
34. Metabolism in human leukocytes of anti-HIV dideoxypurine nucleosides.
Fridland A; Johnson MA; Cooney DA; Ahluwalia G; Marquez VE; Driscoll JS; Johns DG
Ann N Y Acad Sci; 1990; 616():205-16. PubMed ID: 2078020
[TBL] [Abstract][Full Text] [Related]
35. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
Johns DG; Ahluwalia GS; Cooney DA; Mitsuya H; Driscoll JS
Mol Pharmacol; 1993 Sep; 44(3):519-23. PubMed ID: 8371712
[TBL] [Abstract][Full Text] [Related]
36. Cellular pharmacology and anti-HIV activity of 2',3'-dideoxyguanosine.
Busso ME; Resnick L; Yang BH; Mian AM
AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1139-46. PubMed ID: 2265029
[TBL] [Abstract][Full Text] [Related]
37. Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells.
Hershfield MS; Fetter JE; Small WC; Bagnara AS; Williams SR; Ullman B; Martin DW; Wasson DB; Carson DA
J Biol Chem; 1982 Jun; 257(11):6380-6. PubMed ID: 6281270
[No Abstract] [Full Text] [Related]
38. 2',3'-Dideoxynucleoside phosphorylation by deoxycytidine kinase from normal human thymus extracts: activation of potential drugs for AIDS therapy.
Johnson MA; Johns DG; Fridland A
Biochem Biophys Res Commun; 1987 Nov; 148(3):1252-8. PubMed ID: 2825680
[TBL] [Abstract][Full Text] [Related]
39. Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro.
Starnes MC; Cheng YC
J Biol Chem; 1987 Jan; 262(3):988-91. PubMed ID: 2433280
[TBL] [Abstract][Full Text] [Related]
40. Biochemical genetic analysis of 2',3'-dideoxyadenosine metabolism in human T lymphocytes.
Carson DA; Haertle T; Wasson DB; Richman DD
Biochem Biophys Res Commun; 1988 Mar; 151(2):788-93. PubMed ID: 3258154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
